iPath Pure Beta Crude Oil ETN (OIL) Research
This index, called the Barclays WTI Crude Oil Pure Beta Total Return Index, seeks to mirror the potential gains from a straightforward, unleveraged investment in crude oil futures. It has the ability to switch into various futures contracts with differing maturity dates, with these selections made according to the Barclays Pure Beta Series 2 Methodology.
Market snapshot
- Symbol
- OIL
- Price
- $28.42
- Day change
- +0.96%
- Market cap
- $53.1M
- 52-week range
- 25.31-31.449
- Sector
- Financial Services
- Industry
- Asset Management - Global
Recent news
- Oil prices under new wave of pressure amid lingering questions over a Strait of Hormuz reopening
A flurry of headlines on Friday point to an increasingly fragile deal between the U.S. and Iran.
- U.S. Global Investors sees tailwind for airline stocks as oil prices slide
U.S. Global Investors (NASDAQ:GROW) said falling oil prices are providing a boost to airline stocks, pointing to gains in Delta Air Lines and United Airlines as carriers benefit from steady travel demand and lower fuel costs.
- Hormuz Reopening Shifts Focus to Gulf Oil Storage and Shipping
Recovery hinges both on whether tankers can freely transit the strait, and if the region's oil producers can load enough crude once these vessels are ready to sail, according to Rystad Energy.
Peer companies
- DeltaShares S&P 500 Managed Risk ETF (DMRL)
- Invesco DWA Tactical Sector Rotation ETF (DWTR)
- Ecofin Global Water ESG Fund (EBLU)
- Invesco BRIC ETF (EEB)
- Goldman Sachs Data-Driven World ETF (GDAT)
- iShares International Preferred Stock ETF (IPFF)
- Invesco RAFI Strategic Developed ex-US ETF (ISDX)
- AllianzIM U.S. Equity Buffer10 Jul ETF (JULT)
Recent insider activity
- Little Richard H — A-Award (20000 shares) on 2024-10-02
- NANKE KEVIN K — A-Award (15000 shares) on 2024-10-02
- Taillon Brad — A-Award (25000 shares) on 2024-10-02
Open iPath Pure Beta Crude Oil ETN (OIL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.